In our study, we found that downregulation of BCL11A depressed EMT program in NB cells, including upregulation of the epithelial marker E-cadherin, as well as downregulation of mesenchymal markers (N-cadherin, slug, and vimentin). The gene discussed is CDH2; the disease is neuroblastoma.